Wednesday, Aug 12, 2020 | Last Update : 03:48 PM IST

140th Day Of Lockdown

Maharashtra53560136843518306 Tamil Nadu3086492506805159 Andhra Pradesh2445491547492203 Karnataka1886111055993398 Delhi1461341316574131 Uttar Pradesh126722767212120 West Bengal98459671202059 Bihar8274154139450 Telangana8075157586637 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3433121832109 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
  Life   Health  22 Oct 2019  Human bodies get resistant to antibiotics for treating harmful bacteria

Human bodies get resistant to antibiotics for treating harmful bacteria

ANI
Published : Oct 22, 2019, 9:43 am IST
Updated : Oct 22, 2019, 9:43 am IST

Studies reveal that human body resists antibiotics for treating harmful bacteria for multiple stomach conditions.

The research was presented today at UEG Week Barcelona 2019. (Photo: ANI)
 The research was presented today at UEG Week Barcelona 2019. (Photo: ANI)

Washington: A recent study has discovered that the human body starts getting resistant to antibiotics for treating harmful bacteria for a variety of stomach conditions, and the changes have more than doubled in 20 years.

Antibiotic resistance occurs when bacteria develop the ability to survive exposure to medications designed to kill or halt their growth. It is one of the greatest threats to global health today, causing more than 750,000 deaths every year and, without urgent action, this number is expected to rise dramatically in the future.

 

The research was presented today at UEG Week Barcelona 2019. The study analysed 1,232 patients from 18 countries across Europe, investigated resistance to antibiotics regularly taken for 'helicobacter pylori' (H. pylori) infection, a harmful bacterium associated with gastric ulcer, lymphoma, and gastric cancer.

Presenting the study, lead researcher Prof Francis Megraud explained: " 'H pylori infection is already a complex condition to treat, requiring a combination of medications. With resistance rates to commonly used antibiotics such as clarithromycin increasing at an alarming rate of nearly one per cent per year, treatment options for 'H pylori' will become progressively limited and ineffective if novel treatment strategies remain undeveloped."

 

'H pylori' is one of the most common bacterial infections in humans and is estimated to be present in one-half of the world's population. 'H pylori' leads to inflammation of the stomach lining, namely gastritis, which can result in peptic ulcers.

Underlining the severity of the situation, in 2017, the World Health Organisation (WHO) identified clarithromycin-resistant 'H pylori' as a high priority bacterium for antibiotic research and development.

The survey also found that the rates of primary clarithromycin resistance in 'H pylori' were highest in southern Italy (39.9 per cent), Croatia (34.6 per cent) and Greece (30 per cent), aligning with previous reports that predict that both Italy and Greece will have the highest number of deaths due to antimicrobial resistance amongst EU members by 20507.

 

The high levels of resistance exhibited in these countries have been attributed to the overconsumption of antibiotics for conditions including cold and flu, and a lack of institutional support for antibiotic resistance containment strategies.

"The findings of this study are certainly concerning, as 'H pylori' is the main cause of peptic disease and gastric cancer," commented Mario Dinis-Ribeiro, president of the European Society of Gastrointestinal Endoscopy. "The increasing resistance of 'H pylori' to a number of commonly-used antibiotics may jeopardise prevention strategies."

Tags: antibiotics, bacteria, gastric cancer